Yubo International Biotech Limited Stock Other OTC
Equities
YBGJ
US9883661004
Biotechnology & Medical Research
Financials (USD)
Sales 2022 | 0.1 | Sales 2023 | 0.6 | Capitalization | 35.95M |
---|---|---|---|---|---|
Net income 2022 | -1M | Net income 2023 | -1M | EV / Sales 2022 | 116,560,264 x |
Net Debt 2022 | 772K | Net Debt 2023 | 386K | EV / Sales 2023 | 60,084,725 x |
P/E ratio 2022 |
-9.36
x | P/E ratio 2023 |
-30.1
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 6.63% |
Managers | Title | Age | Since |
---|---|---|---|
Jun Wang
CEO | Chief Executive Officer | 57 | 18-12-31 |
Lina Liu
DFI | Director of Finance/CFO | 45 | 18-12-31 |
Wang Yang
BRD | Director/Board Member | 45 | 18-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Wang Yang
BRD | Director/Board Member | 45 | 18-12-31 |
Lina Liu
DFI | Director of Finance/CFO | 45 | 18-12-31 |
Zhi Hui Bai
BRD | Director/Board Member | 39 | 19-12-31 |
1st Jan change | Capi. | |
---|---|---|
+45.91% | 56.69B | |
-3.52% | 41B | |
+39.84% | 38.11B | |
-11.22% | 26.89B | |
+9.71% | 25.59B | |
-21.54% | 18.59B | |
-1.01% | 12.39B | |
+24.66% | 11.99B | |
+22.41% | 11.88B |